Evidence map›Paper›PMID 12857913›Full record

ArticleJournal of virology2003

Equine infectious anemia virus utilizes host vesicular protein sorting machinery during particle release.

Giancarlo O Tanzi, Andrew J Piefer, Paul Bates

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. A crescent-shaped ALIX dimer targets ESCRT-III CHMP4 filaments.Structure (London, England : 1993) · 2009
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Giancarlo O TanziDepartment of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6076, USA.
Andrew J Piefer
Paul Bates
University of Pennsylvania · US

Funding

TRAINING PROGRAM IN CELL AND MOLECULAR BIOLOGYT32GM007229 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI BARTOLOMEI, MARISA S. · 1985 to 2023
$14.0M
TRAINING IN NEUROVIROLOGY AND NEUROIMMUNOLOGYT32NS007180 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI WEISS, SUSAN R · 1985 to 2018
$2.8M
NIGMS NIH HHS T32 GM007229NIGMS NIH HHS T32-GM07229NINDS NIH HHS T32 NS007180NINDS NIH HHS T32-NS07180
6 · The paper itself

Abstract

A final step in retrovirus assembly, particle release from the cell, is modulated by a small motif in the Gag protein known as a late domain. Recently, human immunodeficiency virus type 1 (HIV-1) and Moloney murine leukemia virus (M-MuLV) were shown to require components of the cellular vacuolar protein sorting (VPS) machinery for efficient viral release. HIV-1 interacts with the VPS pathway via an association of HIV-1 Gag with TSG101, a component of the cellular complexes involved in VPS. Equine infectious anemia virus (EIAV) is unique among enveloped viruses studied to date because it utilizes a novel motif, YPDL in Gag, as a late domain. Our analysis of EIAV assembly demonstrates that EIAV Gag release is blocked by inhibition of the VPS pathway. However, in contrast to HIV-1, EIAV Gag release is insensitive to TSG101 depletion and EIAV particles do not contain significant levels of TSG101. Finally, we demonstrate that fusing EIAV Gag directly with another cellular component of the VPS machinery, VPS28, can restore efficient release of an EIAV Gag late-domain mutant. These results provide evidence that retroviruses can interact with the cellular VPS machinery in several different ways to accomplish particle release.

Indexed as

AnimalsCell LineDNA-Binding ProteinsEndosomal Sorting Complexes Required for TransportGene Products, gagGTPase-Activating ProteinsHeLa CellsHumansInfectious Anemia Virus, EquineMicroscopy, FluorescenceMutationProtein TransportTranscription FactorsTsg101 ProteinVesicular Transport ProteinsVirionDNA-Binding ProteinsEndosomal Sorting Complexes Required for TransportGene Products, gagGTPase-Activating ProteinsTranscription FactorsTsg101 ProteinVesicular Transport ProteinsVPS28 protein, human

Identifiers

PMID12857913
PMCPMC165230
OpenAlexW2130960718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.